Cybin Inc. (HELP) Income Statement

NASDAQ: HELPRevenue, profits, margins and EPS over 6 years.

HELP FY2026 at a glance

Fiscal year ended March 31, 2026 · U.S. dollars
Revenue−100.0%
$0
FY2026 · hover or tap a bar for each year
FY2017: $0FY2018: $0FY2019: $0FY2020: $0FY2021: $864,000FY2026: $0 (−100.0%)
FY2017FY2026
Gross profit
−$44.8M
FY2026 · hover or tap a bar for each year
FY2021: −$311,000FY2026: −$44.8M
FY2017FY2026
Operating income
−$141.7M
FY2026 · hover or tap a bar for each year
FY2017: −$127,000FY2018: −$189,946FY2019: −$80,520FY2020: −$2.0MFY2021: −$31.0MFY2026: −$141.7M
FY2017FY2026
Net income
−$147.1M
FY2026 · hover or tap a bar for each year
FY2017: −$127,000FY2018: −$220,806FY2019: −$101,000FY2020: −$1.9MFY2021: −$32.2MFY2026: −$147.1M
FY2017FY2026
EPS (diluted)
−$5.00
FY2026 · hover or tap a bar for each year
FY2017: −$0.43FY2018: −$0.61FY2019: −$0.08FY2020: −$0.67FY2021: −$6.55FY2026: −$5.00
FY2017FY2026

HELP revenue and net income

RevenueNet incomeNet margin (right axis)

HELP profit margins

GrossOperatingNet

HELP growth rates

to FY2026
1 year3 years5 years10 years
Revenue−100.0%———
Gross profit————
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

HELP quarterly EPS vs estimates

Reported EPSAnalyst estimate

Cybin beat the analyst EPS estimate in 2 of the last 7 quarters. Next report: November 12, 2026 (estimate $-0.67).

HELP income statement

Cybin Inc. annual income statement
FY2026FY2021FY2020FY2019FY2018FY2017
Revenue$0$864,000$0$0$0$0
Cost of revenue$119,232$1.2M————
Gross profit−$44.8M−$311,000————
Research & development$86.0M$3.3M$321,600———
Sales, general & admin$49.6M$27.4M$1.6M———
Total operating expenses$96.9M$30.7M$1.9M$80,524$189,946$127,216
Operating income−$141.7M−$31.0M−$2.0M−$80,520−$189,946−$127,000
Interest income$5.1M—————
Interest expense$4.0M$10,000————
Income before taxes−$57.7M−$32.2M−$1.9M−$101,000−$220,806−$127,000
Income taxes$89.4M—————
Net income−$147.1M−$32.2M−$1.9M−$101,000−$220,806−$127,000
EBITDA−$141.6M−$31.0M$9,600−$80,913−$220,806−$127,000
EPS (diluted)−$5.00−$6.55−$0.67−$0.08−$0.61−$0.43
Gross margin—−36.0%————
Operating margin—−3,592.0%————
Net margin—−3,729.2%————

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in HELP's financial statements (latest annual report filed March 31, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

HELP financial results

Cybin reported no revenue in fiscal year 2026 (ended March 31, 2026). It had a net loss of $147.1 million. Diluted earnings per share came to −$5.00.

See the HELP stock overview for the latest quote and news, or the HELP chart for price history and technical indicators.

HELP income statement FAQ

Does Cybin have revenue?

Cybin reported no revenue for fiscal year 2026, which ended on March 31, 2026.

Is Cybin profitable?

No. Cybin reported a net loss of $147.1 million in fiscal 2026.

How much does Cybin spend on research and development?

Cybin spent $86.0 million on research and development in fiscal 2026.

What are Cybin's earnings per share?

Cybin earned $-5.00 per diluted share in fiscal 2026, compared with $-6.55 a year earlier.

When will Cybin report its next earnings?

Cybin is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 before the market opens.

When does Cybin's fiscal year end?

Cybin's fiscal year ends in March. The latest annual report covers the year ended March 31, 2026 and was filed on March 31, 2026.

Biotechnology income statements